Innovasis, Inc.

Innovasis, Inc. is a US-based company focused on developing advanced biomaterials and medical devices specifically designed for spinal fusion procedures. Founded in 2004 and headquartered in Salt Lake City, US, Innovasis, Inc. specializes in medical technology for spinal applications.

The company has undertaken strategic pivots to enhance its product line and expand its market reach. The most recent deal involved Innovasis being acquired by Roots Equity Group on November 14, 2025, with financial terms undisclosed. Innovasis specializes in advanced biomaterials and medical devices for spinal fusion procedures, primarily focusing on interbody fusion devices. Their core product offerings include HA PEEK, a high-performance material that integrates hydroxyapatite (HA) within a PEEK-OPTIMA matrix, enhancing osteoconductivity and facilitating bone apposition.

The company also offers AxTiHA and TxTiHA, 3D-printed titanium interbody cages featuring Tetracell™ scaffold technology, which boasts up to 66% porosity for improved osseointegration. These products are designed for use in various spinal applications, including cervical, thoracolumbar, and cranial surgeries, addressing the needs of neurosurgeons, orthopedic surgeons, and healthcare facilities worldwide. Innovasis's solutions are marketed primarily across North America and Europe, catering to a diverse clientele that includes hospitals, surgical centers, and specialized clinics. Innovasis operates on a B2B model, engaging directly with healthcare providers, hospitals, and medical device distributors to supply its specialized products.

Revenue is generated through the sale of its flagship products, such as HA PEEK and HAnano Surface® implant modifications, which are integral to surgical procedures aimed at spinal fusion. Transactions typically occur through bulk orders by hospitals or surgical centers, where pricing structures are tailored to the volume and frequency of purchases. While specific pricing plans for individual products are proprietary, substantial orders can lead to negotiated pricing agreements, reflecting the company's commitment to serving its clients effectively while ensuring competitive market positioning. Following the acquisition by Roots Equity Group, Innovasis, Inc.

aims to innovate and enhance its treatment solutions, expanding into a broader range of healthcare sectors. Future plans include the design and launch of new products tailored for spinal fusion, with anticipated release dates to be announced following the integration with the acquiring firm. The acquisition will also support entering new geographic markets, particularly targeting expansion into Asia and additional European countries by 2026. These initiatives will be bolstered by the financial backing received from the acquisition, enabling the company to pursue development and market entry strategies more aggressively.